The fibrin-derived peptide Bβ15-42 attenuates liver damage in a rat model of liver ischemia/reperfusion injury

Shock

Volumn 39, Issue 4, 2013, Pages 397-403

  Liu, Anding ^a,b   Fang, Haoshu ^b   Yang, Yan ^a   Sun, Jian ^c   Fan, Hua ^d   Liu, Shenpei ^a   Dirsch, Olaf ^b   Dahmen, Uta ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

B 15 42; fibrinogen; HMGB1; inflammatory response; Liver ischemia reperfusion; MAPK

Indexed keywords

AMINOTRANSFERASE; FIBRIN DERIVATIVE; FIBRINOGEN; FIBRINOGEN ALPHA; FIBRINOGEN BETA; FIBRINOGEN GAMMA; HIGH MOBILITY GROUP B1 PROTEIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDE BBETA 15 42; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HISTOPATHOLOGY; LIVER INJURY; LIVER ISCHEMIA; LIVER PERFUSION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; REPERFUSION; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; CYTOKINES; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HMGB1 PROTEIN; LIVER; MALE; MAP KINASE SIGNALING SYSTEM; NEUTROPHIL INFILTRATION; PEPTIDE FRAGMENTS; RATS; RATS, INBRED LEW; REPERFUSION INJURY; TRANSAMINASES;

EID: 84875366869     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31828c2b75     Document Type: Article

References (39)

1. Fondevila C, Busuttil RW, Kupiec-Weglinski JW: Hepatic ischemia/reperfusion injuryVa fresh look. Exp Mol Pathol 74(2):86-93, 2003. (Pubitemid 36438656)
2. Selzner N, Rudiger H, Graf R, Clavien PA: Protective strategies against ischemic injury of the liver. Gastroenterology 125(3):917-936, 2003. (Pubitemid 37070708)
3. de Rougemont O, Lehmann K, Clavien PA: Preconditioning, organ preservation, and postconditioning to prevent ischemia-reperfusion injury to the liver. Liver Transpl 15(10):1172-1182, 2009.
4. Vardanian AJ, Busuttil RW, Kupiec-Weglinski JW: Molecular mediators of liver ischemia and reperfusion injury: a brief review. Mol Med 14(5-6):337-345, 2008. (Pubitemid 351785707)
5. Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, Pina E, Geller DA: Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res 147(1):153-159, 2008. (Pubitemid 351626076)
6. Dulkanchainun TS, Goss JA, Imagawa DK, Shaw GD, Anselmo DM, Kaldas F, Wang T, Zhao D, Busuttil AA, Kato H, et al.: Reduction of hepatic ischemia/ reperfusion injury by a soluble P-selectin glycoprotein ligand-1. Ann Surg 227(6): 832-840, 1998. (Pubitemid 29119530)
7. Teoh NC, Ito Y, Field J, Bethea NW, Amr D, McCuskey MK, McCuskey RS, Farrell GC, Allison AC: Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice. Gastroenterology 133(2):632-646, 2007. (Pubitemid 47187352)
8. Hamada T, Fondevila C, Busuttil RW, Coito AJ: Metalloproteinase-9 deficiency protects against hepatic ischemia/reperfusion injury. Hepatology 47(1):186-198, 2008. (Pubitemid 351171056)
9. Vestweber D: VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 28(2):223-232, 2008. (Pubitemid 351161193)
10. Gorlatov S, Medved L: Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: mapping of the receptor-binding site in the NH2-terminal portions of the fibrin beta chains. Biochemistry 41(12):4107-4116, 2002. (Pubitemid 34251050)
11. Zacharowski K, Zacharowski P, Reingruber S, Petzelbauer P: Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarction. J Mol Med (Berl) 84(6):469-477, 2006. (Pubitemid 43801325)
12. Groger M, Pasteiner W, Ignatyev G, Matt U, Knapp S, Atrasheuskaya A, Bukin E, Friedl P, Zinkl D, Hofer-Warbinek R, et al.: Peptide Bbeta(15-42) preserves endothelial barrier function in shock. PLoS One 4(4):e5391, 2009.
13. Petzelbauer P, Zacharowski PA, Miyazaki Y, Friedl P, Wickenhauser G, Castellino FJ, Groger M, Wolff K, Zacharowski K: The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury. Nat Med 11(3):298-304, 2005. (Pubitemid 40460558)
14. Roesner JP, Petzelbauer P, Koch A, Mersmann J, Zacharowski PA, Boehm O, Reingruber S, Pasteiner W, Mascher D, Wolzt M, et al.: The fibrin-derived peptide Bbeta15-42 is cardioprotective in a pig model of myocardial ischemiareperfusion injury. Crit Care Med 35(7):1730-1735, 2007. (Pubitemid 46985877)
15. Zacharowski K, Zacharowski PA, Friedl P, Mastan P, Koch A, Boehm O, Rother RP, Reingruber S, Henning R, Emeis JJ, et al.: The effects of the fibrinderived peptide Bbeta(15-42) in acute and chronic rodent models of myocardial ischemia-reperfusion. Shock 27(6):631-637, 2007. (Pubitemid 46788162)
16. Atar D, Petzelbauer P, Schwitter J, Huber K, Rensing B, Kasprzak JD, Butter C, Grip L, Hansen PR, Suselbeck T, et al.: Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. J Am Coll Cardiol 53(8): 720-729, 2009.
17. Sorensen I, Rong S, Susnik N, Gueler F, Shushakova N, Albrecht M, Dittrich AM, von Vietinghoff S, Becker JU, Melk A, et al.: Bbeta(15-42) attenuates the effect of ischemia-reperfusion injury in renal transplantation. J Am Soc Nephrol 22(10):1887-1896, 2011.
18. Roesner JP, Petzelbauer P, Koch A, Tran N, Iber T, Vagts DA, Scheeren TW, Vollmar B, Noldge-Schomburg GE, Zacharowski K: Bbeta15-42 (FX06) reduces pulmonary, myocardial, liver, and small intestine damage in a pig model of hemorrhagic shock and reperfusion. Crit Care Med 37(2):598-605, 2009.
19. Jennewein C, Mehring M, Tran N, Paulus P, Ockelmann PA, Habeck K, Latsch K, Scheller B, Zacharowski K, Mutlak H: The fibrinopeptide bbeta15-42 reduces inflammation in mice subjected to polymicrobial sepsis. Shock 38(3): 275-280, 2012.
20. Krishnamoorthy A, Ajay AK, Hoffmann D, Kim TM, Ramirez V, Campanholle G, Bobadilla NA, Waikar SS, Vaidya VS: Fibrinogen beta-derived Bbeta(15-42) peptide protects against kidney ischemia/reperfusion injury. Blood 118(7): 1934-1942, 2011.
21. Liu A, Dirsch O, Fang H, Sun J, Jin H, Dong W, Dahmen U: HMGB1 in ischemic and non-ischemic liver after selective warm ischemia/reperfusion in rat. Histochem Cell Biol 135(5):443-452, 2011.
22. Moloney WC, Mcpherson K, Fliegelman L: Esterase activity in leukocytes demonstrated by the use of naphthol AS-D chloroacetate substrate. J Histochem Cytochem 8:200-207, 1960.
23. Schlayer HJ, Woort-Menker M, Eyhorn S, Becker H, Schaefer HE, Decker K: Beta-glucuronidase and chloroacetate-esterase staining discriminates rat liver sinusoidal endothelial cells from Kupffer cells in primary culture. Virchows Arch B Cell Pathol Incl Mol Pathol 55(4):225-232, 1988.
24. Leder LD: Diagnostic experiences with the naphthol AS-D chloroacetate esterase reaction. Blut 21(1):1-8, 1970.
25. Liu A, Dirsch O, Fang H, Dong W, Jin H, Huang H, Sun J, Dahmen U: HMGB1 translocation and expression is caused by warm ischemia reperfusion injury, but not by partial hepatectomy in rats. Exp Mol Pathol 91(2):502-508, 2011.
26. Wiedemann D, Schneeberger S, Friedl P, Zacharowski K, Wick N, Boesch F, Margreiter R, Laufer G, Petzelbauer P, Semsroth S: The fibrin-derived peptide Bbeta(15-42) significantly attenuates ischemia-reperfusion injury in a cardiac transplant model. Transplantation 89(7):824-829, 2010.
27. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA, et al.: The nuclear factorHMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201(7):1135-1143, 2005. (Pubitemid 40524681)
28. Bradham CA, Stachlewitz RF, Gao W, Qian T, Jayadev S, Jenkins G, Hannun Y, Lemasters JJ, Thurman RG, Brenner DA: Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases. Hepatology 25(5):1128-1135, 1997. (Pubitemid 27199939)
29. Drew AF, Liu H, Davidson JM, Daugherty CC, Degen JL: Wound-healing defects in mice lacking fibrinogen. Blood 97(12):3691-3698, 2001.
30. Ryu JK, Davalos D, Akassoglou K: Fibrinogen signal transduction in the nervous system. J Thromb Haemost 7(suppl 7):151-154, 2009.
31. Harada N, Okajima K, Uchiba M: Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion- induced liver injury in rats. Crit Care Med 34(7):1883-1891, 2006. (Pubitemid 43982463)
32. Loike JD, Sodeik B, Cao L, Leucona S, Weitz JI, Detmers PA, Wright SD, Silverstein SC: CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A alpha chain of fibrinogen. Proc Natl Acad Sci U S A 88(3): 1044-1048, 1991. (Pubitemid 21916161)
33. Bustin M, Reeves R: High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol 54:35-100, 1996.
34. Bianchi ME, Beltrame M, Paonessa G: Specific recognition of cruciform DNA by nuclear protein HMG1. Science 243(4894 Pt 1):1056-1059, 1989. (Pubitemid 19072581)
35. Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A: HMGB1: endogenous danger signaling. Mol Med 14(7-8):476-484, 2008.
36. Lotze MT, Tracey KJ: High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5(4):331-342, 2005. (Pubitemid 40516158)
37. Czaja MJ, Liu H, Wang Y: Oxidant-induced hepatocyte injury from menadione is regulated by ERK and AP-1 signaling. Hepatology 37(6):1405-1413, 2003. (Pubitemid 36667321)
38. Uehara T, Bennett B, Sakata ST, Satoh Y, Bilter GK, Westwick JK, Brenner DA: JNK mediates hepatic ischemia reperfusion injury. J Hepatol 42(6):850-859, 2005. (Pubitemid 40693202)
39. Kobayashi M, Takeyoshi I, Yoshinari D, Matsumoto K, Morishita Y: P38 mitogen-activated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver. Surgery 131(3):344-349, 2002. (Pubitemid 34229789)